English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 118 | Tables: 119 | Medical Care
The global CRISPR and CRISPR-Associated (Cas) Genes market was valued at US$ 3087 million in 2025 and is anticipated to reach US$ 20920 million by 2032, at a CAGR of 31.9% from 2026 to 2032.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell"s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS"s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report delivers a comprehensive overview of the global CRISPR and CRISPR-Associated (Cas) Genes market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CRISPR and CRISPR-Associated (Cas) Genes. The CRISPR and CRISPR-Associated (Cas) Genes market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global CRISPR and CRISPR-Associated (Cas) Genes market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist CRISPR and CRISPR-Associated (Cas) Genes manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Segment by Type
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for CRISPR and CRISPR-Associated (Cas) Genes companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2021–2032)
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2021–2026)
2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2027–2032)
2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2021–2026)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2021–2026)
3.2 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2025
3.5 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Head Offices and Areas Served
3.6 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Products and Applications
3.7 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2021–2026)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2027–2032)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2021–2026)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)
6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)
7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)
8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2021–2026)
8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)
9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)
9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2021–2032)
10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2021–2026)
10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.2.5 Editas Medicine Recent Development
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Details
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.3.5 Caribou Biosciences Recent Development
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Details
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.4.5 CRISPR therapeutics Recent Development
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Details
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.5.5 Intellia therapeutics, Inc. Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.6.5 Cellectis Recent Development
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Details
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.7.5 Horizon Discovery Plc Recent Development
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Details
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.8.5 Sigma Aldrich Recent Development
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Details
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.9.5 Precision Biosciences Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.10.5 Genscript Recent Development
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Details
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.11.5 Sangamo Biosciences Inc. Recent Development
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Details
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.12.5 Lonza Group Limited Recent Development
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Details
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.13.5 Integrated DNA Technologies Recent Development
11.14 New England Biolabs
11.14.1 New England Biolabs Company Details
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.14.5 New England Biolabs Recent Development
11.15 Origene Technologies
11.15.1 Origene Technologies Company Details
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
11.15.5 Origene Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million), 2021–2026
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2021–2026)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (US$ Million), 2027–2032
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2027–2032)
Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (US$ Million), 2021–2026
Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players (2021–2026)
Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Tier (Tier 1, Tier 2, and Tier 3), based on CRISPR and CRISPR-Associated (Cas) Genes Revenue, 2025
Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2025
Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI), 2021–2026
Table 24. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Headquarters and Area Served
Table 25. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Products and Applications
Table 26. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of General Availability (GA)
Table 27. Mergers and Acquisitions, Expansion Plans
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (US$ Million), 2021–2026
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2021–2026)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (US$ Million), 2027–2032
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2027–2032)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (US$ Million), 2021–2026
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2021–2026)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (US$ Million), 2027–2032
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2027–2032)
Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026
Table 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032
Table 42. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 43. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million), 2021–2026
Table 44. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million), 2027–2032
Table 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026
Table 47. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032
Table 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2021–2026
Table 50. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (US$ Million), 2027–2032
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 54. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Editas Medicine Company Details
Table 57. Editas Medicine Business Overview
Table 58. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 59. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 60. Editas Medicine Recent Development
Table 61. Caribou Biosciences Company Details
Table 62. Caribou Biosciences Business Overview
Table 63. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 64. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 65. Caribou Biosciences Recent Development
Table 66. CRISPR therapeutics Company Details
Table 67. CRISPR therapeutics Business Overview
Table 68. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 69. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 70. CRISPR therapeutics Recent Development
Table 71. Intellia therapeutics, Inc. Company Details
Table 72. Intellia therapeutics, Inc. Business Overview
Table 73. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 74. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 75. Intellia therapeutics, Inc. Recent Development
Table 76. Cellectis Company Details
Table 77. Cellectis Business Overview
Table 78. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 79. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 80. Cellectis Recent Development
Table 81. Horizon Discovery Plc Company Details
Table 82. Horizon Discovery Plc Business Overview
Table 83. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 84. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 85. Horizon Discovery Plc Recent Development
Table 86. Sigma Aldrich Company Details
Table 87. Sigma Aldrich Business Overview
Table 88. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
Table 89. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 90. Sigma Aldrich Recent Development
Table 91. Precision Biosciences Company Details
Table 92. Precision Biosciences Business Overview
Table 93. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 94. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 95. Precision Biosciences Recent Development
Table 96. Genscript Company Details
Table 97. Genscript Business Overview
Table 98. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 99. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 100. Genscript Recent Development
Table 101. Sangamo Biosciences Inc. Company Details
Table 102. Sangamo Biosciences Inc. Business Overview
Table 103. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 104. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 105. Sangamo Biosciences Inc. Recent Development
Table 106. Lonza Group Limited Company Details
Table 107. Lonza Group Limited Business Overview
Table 108. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 109. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 110. Lonza Group Limited Recent Development
Table 111. Integrated DNA Technologies Company Details
Table 112. Integrated DNA Technologies Business Overview
Table 113. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 114. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 115. Integrated DNA Technologies Recent Development
Table 116. New England Biolabs Company Details
Table 117. New England Biolabs Business Overview
Table 118. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 119. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 120. New England Biolabs Recent Development
Table 121. Origene Technologies Company Details
Table 122. Origene Technologies Business Overview
Table 123. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 124. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (US$ Million), 2021–2026
Table 125. Origene Technologies Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2025 vs 2032
Figure 4. Genome Editing Features
Figure 5. Genetic engineering Features
Figure 6. gRNA Database/Gene Librar Features
Figure 7. CRISPR Plasmid Features
Figure 8. Human Stem Cells Features
Figure 9. Genetically Modified Organisms/Crops Features
Figure 10. Cell Line Engineering Features
Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (US$ Million), 2021–2032
Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2025 vs 2032
Figure 13. Biotechnology Companies Case Studies
Figure 14. Pharmaceutical Companies Case Studies
Figure 15. Academic Institutes Case Studies
Figure 16. Research and Development Institutes Case Studies
Figure 17. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2025 vs 2032
Figure 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2025
Figure 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2025
Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)
Figure 26. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)
Figure 30. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Ireland CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2021–2032)
Figure 38. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. India CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Australia & New Zealand CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)
Figure 46. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2021–2032)
Figure 50. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 54. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 55. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 56. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 57. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 58. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 59. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 60. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 61. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 62. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 63. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 64. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 65. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 66. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 67. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2021–2026)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
